Skip to main content

Table 1 Demographic factors and clinical characteristics of acute ischemic stroke patients with a history of diabetes divided by telestroke status

From: The telestroke and thrombolysis therapy in diabetic stroke patients

Characteristic

Non-telestroke

Telestroke

P-value

(N = 180)

(N = 132)

Patient age in years

 Mean ± SD

69.3 ± 12.7

65.9 ± 12.3

0.020*

Age group: no. (%)

 < 50 years

14 (7.8)

11 (8.3)

0.069

 50–59

26 (14.4)

20 (15.2)

 

 60–69

43 (23.9)

49 (37.1)

 

 70–79

54 (30)

33 (25)

 

 ≥ 80

43 (23.9)

19 (14.4)

 

Gender: no. (%)

 Male

88 (48.9)

69 (52.3)

0.555

 Female

92 (51.1)

63 (47.7)

 

Race: no. (%)

 Caucasian

127 (70.6)

102 (77.3)

0.212

 African-American

32 (17.8)

19 (14.4)

 

 Other

3 (1.7)

3 (2.3)

 

Hispanic ethnicity: no. (%)

5 (2.8)

6 (4.5)

0.403

Body mass index

 Mean ± SD

29.5 ± 7.3

32.2 ± 7.5

0.001*

Medical history: no. (%)

 Atrial fib/flutter

39 (21.7)

11 (8.3)

0.002*

 Carotid artery stenosis

12 (6.7)

6 (4.5)

0.427

 Congestive heart failure

28 (15.6)

17 (12.9)

0.506

 Coronary artery disease

80 (44.4)

62 (47)

0.658

 Depression

1 (0.6)

27 (20.5)

< 0.001*

 Dyslipidemia

124 (68.9)

92 (69.7)

0.879

 Family history of stroke

14 (7.8)

24 (18.2)

0.006*

 Hormone replacement therapy

3 (1.7)

3 (2.3)

0.7

 Hypertension

165 (91.7)

123 (93.2)

0.62

 Migraine

5 (2.8)

4 (3)

0.895

 Obesity

78 (43.3)

85 (64.4)

< 0.001*

 Peripheral vascular disease

23 (12.8)

11 (8.3)

0.213

 Previous stroke

73 (40.6)

31 (23.5)

0.002*

 Previous TIA

22 (12.2)

9 (6.8)

0.115

 Prosthetic heart valve

1 (0.6)

0 (0)

0.391

 Renal insufficiency

24 (13.3)

9 (6.8)

0.065

 Sleep apnea

0 (0)

11 (8.3)

< 0.001*

 Smoking

41 (22.8)

25 (18.9)

0.412

 Substance abuse

5 (2.8)

2 (1.5)

0.457

Initial NIH stroke scale

 Mean ± SD

10.8 ± 8.6

8.9 ± 7.6

0.063

Initial labs and vitals

 Total cholesterol

165.7 ± 56.9

165.1 ± 43.4

0.885

 Triglycerides

157.3 ± 118.4

159.3 ± 106.1

0.307

 HDL

39.4 ± 12.9

37.8 ± 11.7

0.565

 LDL

95.8 ± 36.5

98.4 ± 35.3

0.889

 Lipids

7.6 ± 2.1

7.6 ± 2.1

0.067

 Blood glucose

195.8 ± 115.2

173 ± 97

0.054

 Creatinine

1.5 ± 1.1

1.2 ± 1

0.007*

 INR

1.1 ± 0.3

1 ± 0.2

0.074

 Heart rate

84.1 ± 19.2

80.4 ± 16.9

0.097

 Systolic blood pressure

155.9 ± 33.2

150.6 ± 23.6

0.158

 Diastolic blood pressure

81.8 ± 19.2

78.8 ± 17.1

<0.001*

Medications prior to admission: no. (%)

 Antiplatelet or anticoagulant

112 (62.2)

79 (59.8)

0.671

 Antihypertensive

150 (83.3)

114 (86.4)

0.464

 Cholesterol reducer

113 (62.8)

91 (68.9)

0.258

 Diabetic medication

128 (71.1)

100 (75.8)

0.361

Ambulation status prior to event: no. (%)

 Ambulate independently

148 (82.2)

121 (91.7)

0.106

 Ambulate with assistance

12 (6.7)

3 (2.3)

 

 Unable to ambulate

11 (6.1)

5 (3.8)

 

 Not documented

9 (5)

3 (2.3)

 

Ambulation status on admission: no. (%)

 Ambulate independently

20 (11.1)

26 (19.7)

0.016*

 Ambulate with assistance

18 (10)

23 (17.4)

 

 Unable to ambulate

75 (41.7)

39 (29.5)

 

 Not documented

67 (37.2)

44 (33.3)

 

Ambulation status on discharge: no. (%)

 Ambulate independently

69 (38.3)

61 (46.2)

0.044*

 Ambulate with assistance

46 (25.6)

42 (31.8)

 

 Unable to ambulate

47 (26.1)

18 (13.6)

 

 Not documented

18 (10)

11 (8.3)

 

First care received: no. (%)

 Emergency department

159 (88.3)

38 (28.8)

< 0.001*

 Direct admission

21 (11.7)

94 (71.2)

 

rtPA administration

68 (37.8)

114 (86.4)

< 0.001*

Improved ambulation

109 (60.6)

89 (67.4)

0.213

  1. Continuous variables are represented as Mean ± S.D. and comparisons between groups are made with a Student’s T Test. Discrete variables are represented as Count (Percent Frequency) and comparisons between groups were made using Pearson’s Chi Squared
  2. *P < 0.05